| Sandoz Pharmaceuticals AG - Fentalis 400 μg, Sublingualtabletten |
| 67996 | | 04 | | Fentalis 400 μg | | Sublingualtabletten | | N02AB03 | | Fentanyl | | 27.01.2021 | | |
|
| Composition |
| fentanylum 400 µg ut fentanyli citras, mannitolum, cellulosum microcristallinum silicificatum, carmellosum natricum conexum corresp. natrium max. 0.08 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Sublingual tablets | | | | | Active Agent | Dose |
|---|
| Fentanyl | 400 µg |
| | BAG: Active Agent | Dose |
|---|
| Fentanyl | 400 mcg |
| | | | Inactive agents |
|---|
| Carmellosum Natricum Conexum | | Cellulosum Microcristallinum Silicificatum | | Magnesii Stearas | | Mannitol | | Pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 30 | 202.41 | 236.55 | A+ | SL | Yes |
|
